Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update

被引：3

作者：

Cornet, Nicole ^{[1
]}

Aboubakr, Aiya ^{[2
]}

Ahmed, Waseem ^{[3
]}

Battat, Robert ^{[4
]}

机构：

[1] NewYork Presbyterian Weill Cornell Med, Dept Med, New York, NY USA

[2] NewYork Presbyterian Weill Cornell Med, Div Gastroenterol, New York, NY USA

[3] Univ Colorado, Crohns & Colitis Ctr, Dept Gastroenterol, Aurora, CO USA

[4] Ctr Hosp Univ Montreal, Dept Gastroenterol & Hepatol, 1000,Rue St Denis, Montreal, PQ H2X 0C1, Canada

来源：

INFLAMMATORY BOWEL DISEASES | 2024年

关键词：

inflammatory bowel disease; combined advanced targeted therapy; dual advanced therapy; CROHNS-DISEASE; COMBINATION THERAPY; RHEUMATOID-ARTHRITIS; BISPECIFIC ANTIBODY; RISK-FACTORS; SAFETY; INFLIXIMAB; REMISSION; EFFICACY; AZATHIOPRINE;

D O I：

10.1093/ibd/izae189

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This article discusses the rationale for and the current data on the efficacy and safety of combined advanced targeted therapy (CATT) for the treatment of moderate-to-severe inflammatory bowel disease.

引用

页数：7

共 50 条

[1] Update Imaging in Inflammatory Bowel Diseases
Herfarth, Hans
DIGESTIVE DISEASES, 2013, 31 (3-4) : 345 - 350
[2] Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel Disease
Wetwittayakhlang, Panu
Lakatos, Peter L.
JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2023, 7 (01) : 22 - 29
[3] PREDICTORS OF REMISSION TO VEDOLIZUMAB THERAPY IN A COMBINED INFLAMMATORY BOWEL DISEASES COHORT
Subramanian, Sreedhar
Mcpartland, Paula
Dodd, Susie
Storey, Daniel
Steel, Alan
Dibb, Martyn
Collins, Paul
Probert, Chris
Derbyshire, Ed
Davis, Rebecca
GUT, 2018, 67 : A98 - A98
[4] The gastroenterologist's update on inflammatory bowel diseases
Viscido, A
Aratari, A
D'Ovidio, V
Guagnozzi, D
Annovazzi, A
Caprilli, R
NUCLEAR MEDICINE IN THE MANAGEMENT OF INFLAMMATORY AND INFECTIOUS DISEASES, 2003, : 3 - 11
[5] Inflammatory bowel diseases: Update 2023 and perspectives
Zundler, Sebastian
Blumenstein, Irina
GASTROENTEROLOGIE, 2023, 18 (06): : 421 - 422
[6] Cytokines in inflammatory bowel diseases - Update 2020
Leppkes, M.
Neurath, M. F.
PHARMACOLOGICAL RESEARCH, 2020, 158
[7] Biosimilars in the therapy of inflammatory bowel diseases
Hlavaty, Tibor
Letkovsky, Juraj
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (06) : 581 - 587
[8] Conservative therapy of inflammatory bowel diseases
Wedel, S
Lochs, H
CHIRURGISCHE GASTROENTEROLOGIE, 1998, 14 (02): : 112 - 118
[9] Endoscopic Therapy in Inflammatory Bowel Diseases
Neumann, Helmut
Neurath, Markus F.
Atreya, Raja
VISZERALMEDIZIN, 2015, 31 (04): : 280 - 286
[10] Personalizing therapy for inflammatory bowel diseases
Ananthakrishnan, Ashwin N.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (06) : 549 - 558

← 1 2 3 4 5 →